Clinical trial

A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy

NCT03043807

Drugs and interventions used in this trial

5 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Leuprolide Acetate Normalized identity: leuprolide acetateView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Docetaxel Normalized identity: docetaxelView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Bicalutamide Normalized identity: bicalutamideView linked drug · Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention Radiation Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Abiraterone Acetate Normalized identity: abiraterone acetateView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-02-22

PhasePHASE2

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

Leuprolide AcetateDRUG · verified · RxNorm: leuprolide acetate

DocetaxelDRUG · verified · RxNorm: docetaxel

BicalutamideDRUG · verified · RxNorm: bicalutamide

RadiationRADIATION

Abiraterone AcetateDRUG · verified · RxNorm: abiraterone acetate

Sponsors & collaborators

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkinslead sponsor

Mapped research locations

BaltimoreMaryland, United States1 Washington D.C.District of Columbia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03043807 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.